BlackRock, Inc. 13D and 13G filings for Novavax, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Novavax, Inc. NVAX | BlackRock Inc. BLK | 13,450,411 8.400% | 5,014,232 (+59.44%) | Filing |
| 2024-01-26 4:23 pm Purchase | 2023-12-31 | 13G | Novavax, Inc. NVAX | BlackRock Inc. BLK | 8,436,179 7.100% | 3,627,918 (+75.45%) | Filing |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | Novavax, Inc. NVAX | BlackRock Inc. BLK | 4,808,261 5.700% | 397,500 (+9.01%) | Filing |
| 2022-03-11 2:13 pm Unchanged | 2021-12-31 | 13G | Novavax, Inc. NVAX | BlackRock Inc. BLK | 4,410,761 5.800% | 0 (Unchanged) | Filing |
| 2022-02-08 5:05 pm Sale | 2021-12-31 | 13G | Novavax, Inc. NVAX | BlackRock Inc. BLK | 4,410,761 5.800% | -726,870 (-14.15%) | Filing |
| 2021-02-05 07:51 am Purchase | 2020-12-31 | 13G | Novavax, Inc. NVAX | BlackRock Inc. BLK | 5,137,631 8.100% | 3,287,925 (+177.75%) | Filing |